Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dotinurad safety study in type 2 diabetes with hyperuricemia
jRCT1031260640Recruiting
- Sponsor
- NA
- Start
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Single-arm trial of dotinurad in hyperuricemia, sponsored by NA. Primary endpoint: Serum uric acid. Started Nov 2026; status: recruiting.
02
Drugs
dotinurad
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on jRCT1031260640.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1031260640.